Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer Email on "Negligible Evidence" for Neurontin as a Bipolar Drug Is Focus of Lawyers' Tug-of-War
Pfizer Email on "Negligible Evidence" for Neurontin as a Bipolar Drug Is Focus of Lawyers' Tug-of-War
Pfizer Email on "Negligible Evidence" for Neurontin as a Bipolar Drug Is Focus of Lawyers' Tug-of-War
Submitted by
admin
on October 2, 2009 - 10:36am
Source:
BNET Pharma
News Tags:
Pfizer
lawsuits
Neurontin
off-label
Headline:
Pfizer Email on "Negligible Evidence" for Neurontin as a Bipolar Drug Is Focus of Lawyers' Tug-of-War
Do Not Allow Advertisers to Use My Personal information
